Medicenna Therapeutics Corp.

SUSQUEHANNA INTERNATIONAL GROUP, LLP MDNAF

Report date

9/30/2023

Quarter

2023 Q3

Filed

11/14/2023

Shares

10,605

Value ($000)

3

Weight

0.0%

2021 Q1 - 2023 Q3 (5 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q3	11/14/2023	3	0.0%	10,605	9/30/2023
2023 Q2	8/11/2023	26	0.0%	53,732	6/30/2023
2022 Q4	2/14/2023	23	0.0%	48,491	12/31/2022
2022 Q1	5/16/2022	26	0.0%	20,861	3/31/2022
2021 Q1	5/17/2021	114	0.0%	27,823	3/31/2021